Simcere Zaiming Doses First US Patient in SIM0500 Phase 1 Trial
Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced the first US patient has started treatment in the ongoing Phase 1...
Tag : antibody technology
Inhalon Biopharma’s Inhaled RSV Antibody to Enter Trials
New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations nhalon Biopharma, Inc. (Inhalon),...